Feb 16, 2024 · The latest CymaBay Therapeutics stock prices, stock quotes, news, and CBAY history to help you invest and trade smarter. CymaBay Therapeutics (CBAY) Stock Price, News & Analysis $32.18 -0.02 (-0.06%) (As of 02/16/2024 ET) Compare Today's Range $32.12 $32.19 50-Day Range …Sep 9, 2023 ... ON THE VERGE OF BREAKOUT : CBAY STOCK ANALYSIS | CYMABAY THERAPEUTICS STOCK ... PRICE BREAKOUT : MFC STOCK ANALYSIS | MANULIFE FINANCIAL STOCK.This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday. Gilead Sciences is acquiring CymaBay for its lead product candidate, seladelpar. This is a treatment in development to treat primary biliary cholangitis (PBC). Gilead Sciences …Feb 12, 2024 ... ... price Friday. CymaBay shares skyrocketed Monday to an all-time high after the news. Shares of CymaBay Therapeutics (CBAY) ...Ticker Symbol: CBAY: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001042074: CUSIP Number: 23257D103: ISIN Number: US23257D1037CBAY stock returns are also predicted based on historical data. According to our research, CBAY stock is a bad long-term investment. CBAY share price has been in a bear cycle for the past year.3 days ago · A. The latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by LifeSci Capital on Wednesday, February 14, 2024. The analyst firm set a price target for 0.00 expecting CBAY to ... Read more about CBAY stock here. ... In addition, it also sold pre-funded warrants to purchase 2,142,857 shares of common stock in the offering, at a public price of $6.9999 per underlying share ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...Feb 12, 2024 ... ... CBAY stock via a tender offer. That's a 27% premium compared to the stock's closing price last Friday. Gilead Sciences is acquiring CymaBay ...CBAY CymaBay Therapeutics, Inc.Stock Price & Overview. 7.36K followers. $32.19 -0.01 ( -0.03%) 4:00 PM 02/21/24. NASDAQ | $USD | Post-Market: $32.16 -0.03 ( …Shortly after the Monday announcement, CymaBay said that the Food and Drug Administration had accepted its application for approval of seladelpar, and that it would issue a decision in August. Find the latest CymaBay Therapeutics, Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals Market Capitalization, $K 3,652,614 Shares Outstanding, K 113,400 …Jan 14, 2024 · CBAY Historical Data. ... Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR ...TradingView India. View live CymaBay Therapeutics Inc. chart to track its stock's price action. Find market predictions, CBAY financials and market news.Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...You can buy or sell CBAY and other ETFs, options, and stocks. View the real-time CBAY price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule at rbnhd ...Get the latest CymaBay Therapeutics Inc (CBAY) stock quote, news, history and other vital information to help you with your stock trading and investing. See the …The last closing price of CBAY's stock was USD 25.69. What is the market value of Cymabay Therapeu? The most recent market capitalization for CBAY is USD 2.34B. Will Cymabay Therapeu stock go up ? Based on targets from 9 analysts, the average taret price for CBAY is projected at USD 23.77 over the next 12 months. This means that CBAY's …48.33M. MSFT. 404.06. -0.61%. 21.64M. View today's Cymabay Therapeu stock price and latest CBAY news and analysis. Create real-time notifications to follow any changes in the live stock price.CBAY has gained $0.28 from the previous closing price of $23.71 on volume of 535,102 shares. Over the past year the S&P 500 is higher by 23.21% while CBAY has gained 302.52%. CBAY lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for CymaBay Therapeutics Inc stock.CBAY CBAY PRE-MARKET QUOTE CBAY LATEST PRE MARKET TRADES. ... Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.TradingView India. View live CymaBay Therapeutics Inc. chart to track its stock's price action. Find market predictions, CBAY financials and market news.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.3 days ago · CBAY stock jumped 3.5% the day Genfit and Ipsen reported these results on Nov. 13. Genfit shares eked out a fractional gain. ... *Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade ...Dec 18, 2023 ... CymaBay Therapeutics Inc (CBAY) stock is lower by -2.32% while the S&P 500 is up 0.28% as of 9:53 AM on Monday, Dec 18. CBAY is lower by -$0.51 ...Interactive stock price chart for CymaBay Therapeutics, Inc. (CBAY) with real-time updates, full price history, technical analysis and more.Feb 9, 2024 · NASDAQ: CBAY · IEX Real-Time Price · USD. Add to Watchlist 24.95 +0.95 (3.96%) Feb 8, 2024, 3:03 PM EST - Market open. Overview; Financials; Statistics; Forecast; Dividends; Profile; Chart; Statistics; Market Cap; Revenue; CymaBay Therapeutics Revenue. CymaBay Therapeutics had revenue of $31.02M in the twelve …Feb 14, 2024 ... MEGA BREAKOUT : CBAY STOCK ANALYSIS | CYMABAY THERAPEUTICS STOCK. 17 ... Price Action Trading like a Pro - I share my best tips after 14 years.Jun 30, 2023 ... CymaBay Therapeutics Inc (CBAY) stock is unmoved 0% while the S&P 500 is up 0.78% as of 4:00 PM on Thursday, Jun 29. CBAY is unmoved $0.00 from ...Feb 13, 2024 · CymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The company’s shares closed last Monday at $32.21 ...CymaBay Therapeutics (CBAY) (Delayed Data from NSDQ) $32.18 USD -0.02 (-0.06%) Updated Feb 16, 2024 04:00 PM ET After-Market: $32.18 0.00 (0.00%) 7:58 …Feb 12, 2024 · Feb 12 (Reuters) - Gilead Sciences (GILD.O), opens new tab has agreed to buy CymaBay Therapeutics (CBAY.O), opens new tab for $4.3 billion, gaining access to an experimental liver disease ...In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. CymaBay Therapeutics Inc (CBAY) 23.80 -0.02 ( -0.06% ) USD | NASDAQ | Feb 05, 13:04 View eBay Inc. EBAY stock quote prices, financial information, real-time forecasts, and company news from CNN.Nov 8, 2023 · CymaBay Therapeutics Inc. (CBAY) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price ...5 days ago · According to the issued ratings of 13 analysts in the last year, the consensus rating for CymaBay Therapeutics stock is Hold based on the current 11 hold ratings and 2 buy ratings for CBAY. The average twelve-month price prediction for CymaBay Therapeutics is $26.73 with a high price target of $32.50 and a low price target of $12.00. Get CymaBay Therapeutics Inc (CBAY.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsCymaBay Therapeutics (CBAY) (Delayed Data from NSDQ) $32.18 USD -0.02 (-0.06%) Updated Feb 16, 2024 04:00 PM ET After-Market: $32.18 0.00 (0.00%) 7:58 …Feb 12, 2024 · Price Target. Based on short-term price targets offered by 11 analysts, the average price target for CymaBay Therapeutics Inc. comes to $28.45. The forecasts range from a low of $20.00 to a high ... CymaBay (CBAY) Stock Up on Positive Results From PBC Study. ... DiNello bought 50,000 shares at a price of about $4.19 a share, marking a total purchase worth about $209,000. Shares of New York ...Nov 11, 2023 · CymaBay Therapeutics (NASDAQ:CBAY) rose ~11% on Friday as the company prepares to update results from its Phase 3 RESPONSE study for liver disease therapy seladelpar at a medical event in Boston, MA.Jan 30, 2024 · Headquarters. CymaBay Therapeutics 7575 Gateway Blvd Suite 110 Newark, CA 94560 T: (510) 293-8800CymaBay stock skyrocketed Monday after Gilead Sciences announced it will buy it for $4.3 billion. CBAY stock surged almost 25%. ... Realtime quote and/or trade prices are not sourced from all markets.The CymaBay Therapeutics 52-week low stock price is 7.26, which is 77.5% below the current share price. The average CymaBay Therapeutics stock price for the last 52 weeks is 14.09. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. CymaBay Therapeutics Inc. is a biopharmaceutical company. Dec 28, 2023 ... CymaBay Therapeutics (CBAY) is sprinting to the finish line with a breakthrough treatment for a serious liver disease. And it's pushing CBAY ...Dear cbay community, We are delighted to announce a fantastic new feature that will make your shopping experience with us even more rewarding! 🛍️ Introducing: Bulk discounts! 🎊 Buy more now and you can save more! Our latest feature allows you to get amazing discounts on your favorite products when you buy in bulk. The more you buy, the less you pay!Dec 18, 2023 ... CymaBay Therapeutics Inc (CBAY) stock is lower by -2.32% while the S&P 500 is up 0.28% as of 9:53 AM on Monday, Dec 18. CBAY is lower by -$0.51 ...Feb 7, 2024 · CBAY News. 6 days ago - CymaBay Therapeutics to Participate in Upcoming Investment Conferences - GlobeNewsWire 20 days ago - CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire 4 weeks ago - New Published Data Demonstrates Correlation Between Itch Cytokine Interleukin-31 …Technical Analysis for CBAY - CymaBay Therapeutics Inc. Quote; Chart; End-of-Day Trading Signals; Intraday Alerts; Profile; Buy or Sell? News; Discussion ...The CymaBay Therapeutics stock forecast for tomorrow is $ 25.72, which would represent a 0.13% gain compared to the current price. In the next week, the price of CBAY is expected to decrease by -2.50% and hit $ 25.05.. As far as the long-term CymaBay Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting.CymaBay Therapeutics Stock Forecast 2023. In the last five quarters, CymaBay Therapeutics’s Price Target has risen from $8.75 to $27.73 - a 216.91% increase. Ten analysts predict that CymaBay Therapeutics’s share price will increase in the coming year, reaching $32.50. This would represent an increase of 17.2%.Oct 25, 2023 · CymaBay Therapeutics Inc. (CBAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move. CymaBay Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CBAY stock price. Feb 16, 2024 · CBAY, CymaBay Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Here's why making dividend investing a primary strategy as you build your retirement portfolio may not be the best decision. Is building a dividend portfolio a good idea, and what ...Feb 12, 2024 · This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday. Is Cymabay Therapeutics (NASDAQ:CBAY) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company announcements to find out. Last updated Sunday February 18th 1:06pmThis has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday.Aug 2, 2023 · Fintel reports that on August 14, 2023, UBS initiated coverage of Cymabay Therapeutics (NASDAQ:CBAY) with a Buy recommendation.. Analyst Price Forecast Suggests 15.86% Upside. As of August 2, 2023 ...Feb 12, 2024 ... Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of CymaBay Therapeutics, Inc. to Gilead Sciences, ...3 days ago · A. The latest price target for CymaBay Therapeutics ( NASDAQ: CBAY) was reported by LifeSci Capital on Wednesday, February 14, 2024. The analyst firm set a price target for 0.00 expecting CBAY to ... Historical daily share price chart and data for CymaBay Therapeutics since 2014 adjusted for splits and dividends. The latest closing stock price for ...Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cymabay Therapeu stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. ... Cymabay Therapeu stock (CBAY) in USD. 1 CBAY = 24 USD. 1 month. 6 months. 1 year. 5 years. Cymabay Therapeu stock performance at a glance. Check Cymabay Therapeu’s past …CymaBay Therapeutics Inc (CBAY:NSQ) set a new 52-week high during today's trading session when it reached 32.26. Over this period, the share price is up 300.87% ...Jan 29, 2024 · Analyst Price Target for CBAY i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).Feb 16, 2024 · Ticker Symbol: CBAY: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001042074: CUSIP Number: 23257D103: ISIN Number: US23257D1037CBAY stock data, price, and news. View CBAY insider trading, corporate lobbying, Congressional trading, social media sentiment, and more.Feb 12, 2024 ... This has Gilead valuing shares of CBAY stock at $32.50 apiece. CBAY Stock - Why is CymaBay (CBAY) Stock Up 25% Today? Source: Sundry Photography ...Nov 6, 2023 · Over the past 3 months, 14 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. These analysts are typically employed by large Wall Street banks and tasked with ...The average twelve-month price prediction for CymaBay Therapeutics is $26.73 with a high price target of $32.50 and a low price target of $12.00. Learn more on ...CBAY is trading at a 1% premium. Price $23.84 Feb 2, 2024 Fair Value $67.78 Feb 2, 2024 Uncertainty Very High 1-Star Price $25.73The average Cymabay Therapeutics stock price prediction forecasts a potential downside of 4.84% from the current CBAY share price of $32.20. What is CBAY's forecast return on equity (ROE) for 2024-2027?CBAY support price is $23.04 and resistance is $24.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBAY stock will trade within this expected range on the day.Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.Here's why making dividend investing a primary strategy as you build your retirement portfolio may not be the best decision. Is building a dividend portfolio a good idea, and what ...Feb 16, 2024 · The latest CymaBay Therapeutics stock prices, stock quotes, news, and CBAY history to help you invest and trade smarter. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Feb 13, 2024 · CymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The company’s shares closed last Monday at $32.21 ... Nov 6, 2023 · Over the past 3 months, 14 analysts have published their opinion on CymaBay Therapeutics (NASDAQ:CBAY) stock. These analysts are typically employed by large Wall Street banks and tasked with ...The consensus price target hints at a 40.3% upside potential for CymaBay Therapeutics Inc. (CBAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. Cymabay Therapeu stock price (CBAY) NASDAQ: CBAY. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. ... Cymabay Therapeu stock (CBAY) in USD. 1 CBAY = 24 USD. 1 month. 6 months. 1 year. 5 years. Cymabay Therapeu stock performance at a glance. Check Cymabay Therapeu’s past …Nasdaq. 15,942.59 +148.88 ... Shares of clinical-stage biopharmaceutical company CymaBay Therapeutics, Inc. CBAY gained after it announced positive top-line results from its late-stage RESPONSE study.
This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday. Gilead Sciences is acquiring CymaBay for its lead product candidate, seladelpar. This is a treatment in development to treat primary biliary cholangitis (PBC). Gilead Sciences …. Cristiano ronaldo real madrid
Discover historical prices for EBAY stock on Yahoo Finance. View daily, weekly or monthly format back to when eBay Inc. stock was issued.View CymaBay Therapeutics, Inc. CBAY stock quote prices, financial information, real-time forecasts, and company news from CNN.View the latest CBAY earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 5,088.80. DOW 39,131.53. ...CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. The Cymabay Therapeutics Inc stock price fell by -0.279% on the last day (Tuesday, 13th Feb 2024) from $32.21 to $32.12. During the last trading day the stock fluctuated 0.374% from a day low at $32.09 to a day high of $32.21. The price has risen in 6 of the last 10 days and is up by 35.81% over the past 2 weeks.Find out the direct holders, institutional holders and mutual fund holders for CymaBay Therapeutics, Inc. (CBAY). Research CymaBay Therapeutics' (Nasdaq:CBAY) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance …The average one-year price target for CymaBay Therapeutics (NasdaqGS:CBAY) has been revised to 31.36 / share. This is an increase of 12.84% from the prior estimate of 27.80 dated January 16, 2024.CBAY CBAY PRE-MARKET QUOTE CBAY LATEST PRE MARKET TRADES. ... Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.Real time CymaBay Therapeutics (CBAY) stock price quote, stock graph, news & analysis. CymaBay Therapeutics Inc. (CBAY Quick Quote CBAY - Free Report) closed the last trading session at $16.44, gaining 15.2% over the past four weeks, but there could be plenty of upside left in the ...Interactive stock price chart for CymaBay Therapeutics, Inc. (CBAY) with real-time updates, full price history, technical analysis and more.The CymaBay Therapeutics stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of CBAY stock is predicted to drop by -2.56% tomorrow and lose -2.59% in the next 7 days. Aug 14, 2023 · CymaBay Therapeutics stock price target raised to $16 from $8 at B. Riley MarketWatch. Wednesday, May 18, 2022. 07:27 AM ET. CymaBay Therapeutics stock price target cut to $8 from $10 at B. Riley MarketWatch. Wednesday, May 13, 2020. 07:47 AM ET. CymaBay Therapeutics stock price target raised to $6.00 from $1.50 at B. Riley FBR …CymaBay Therapeutics (CBAY) CymaBay Therapeutics received a Hold rating and a $32.50 price target from H.C. Wainwright analyst Ed Arce today. The …CBAY CBAY PRE-MARKET QUOTE CBAY LATEST PRE MARKET TRADES. ... Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.CymaBay Therapeutics Stock Earnings. The value each CBAY share was expected to gain vs. the value that each CBAY share actually gained. CymaBay Therapeutics ( CBAY) reported Q3 2023 earnings per share (EPS) of -$0.32, missing estimates of -$0.29 by 10.04%. In the same quarter last year, CymaBay Therapeutics 's earnings per share …Feb 12, 2024 ... Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of CymaBay Therapeutics, Inc. to Gilead Sciences, ...The average Cymabay Therapeutics stock price prediction forecasts a potential downside of 4.2% from the current CBAY share price of $32.23. What is CBAY's forecast return on equity (ROE) for 2024-2027? Jun 30, 2023 ... CymaBay Therapeutics Inc (CBAY) stock is unmoved 0% while the S&P 500 is up 0.78% as of 4:00 PM on Thursday, Jun 29. CBAY is unmoved $0.00 from ....
Popular Topics
Is lil baby gay | Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.Based on analysts projections #CBAY is expected to experience a price decline over the next year. The current average CBAY price target, as estimated by these analysts, is $0.00.. The predictions for the future CBAY stock price range from a low of $0.00 to a high of $0.00, highlighting the variability of market expectations for CBAY.. It is important to …Find the latest CBAY240216C00034000 (CBAY240216C00034000) stock quote, history, news and other vital information to help you with your stock trading and investing....
Vcr stock price | This has it agreeing to pay $32.50 per share in cash for CBAY stock via a tender offer. That’s a 27% premium compared to the stock’s closing price last Friday. Gilead Sciences is acquiring CymaBay for its lead product candidate, seladelpar. This is a treatment in development to treat primary biliary cholangitis (PBC). Gilead Sciences …CymaBay Therapeutics Inc (CBAY) Stock Price & News - Google Finance Home CBAY • NASDAQ CymaBay Therapeutics Inc Follow Share $32.18 After Hours: $32.13 (0.15%) -0.048 Closed: Feb 16, 4:54:20 PM... 5 days ago · CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that The New England Journal of Medicine (NEJM) has published detailed results from the RESPONSE Phase 3 trial evaluating seladelpar, an investigational …...
Gams download | CBAY CBAY PRE-MARKET QUOTE CBAY LATEST PRE MARKET TRADES. ... Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.Dec 28, 2023 ... CymaBay Therapeutics (CBAY) is sprinting to the finish line with a breakthrough treatment for a serious liver disease. And it's pushing CBAY ......
Canopy growth corp stock price today | Sep 9, 2023 · He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. ... *Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.Historical daily price data is available for up to two years prior to today's date. For more data, Barchart Premier members can download more historical data (going back to Jan. 1, 1980) and can download Intraday, Daily, Weekly, Monthly or Quarterly data on the Historical Data Download page. Additional underlying chart data and study values can ...CBAY stock jumped 3.5% the day Genfit and Ipsen reported these results on Nov. 13. Genfit shares eked out a fractional gain. ... Realtime quote and/or trade prices are not sourced from all markets. ...
The miracle of the cards | These 14 analysts have an average price target of $22.93 versus the current price of CymaBay Therapeutics at $16.55, implying upside. Below is a summary of how these 14 analysts rated CymaBay ...Cymabay Therapeutics (CBAY) Stock Price Performance. Cymabay Therapeutics (CBAY) Stock Key Data ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months....
Slim shady real | CymaBay (CBAY) Stock Up on Positive Results From PBC Study. ... DiNello bought 50,000 shares at a price of about $4.19 a share, marking a total purchase worth about $209,000. Shares of New York ...Company Profile. CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. The company is headquartered in Newark California, California and currently employs 60 full-time employees. The company went IPO on 2014-01-16....